Circadian rhythm characteristics of oral squamous cell carcinoma growth in an orthotopic xenograft model

OncoTargets and Therapy

Volumn 6, Issue , 2013, Pages 41-46

  Zhao, Ningbo ^a   Tang, Hong ^a   Yang, Kai ^a   Chen, Dan ^a  

^a THE FIRST AFFILIATED HOSPITAL OF CHONGQING MEDICAL UNIVERSITY   (China)

Author keywords

Apoptosis; Oral carcinoma; Proliferation

Indexed keywords

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOTIC INDEX; ARTICLE; CANCER GROWTH; CIRCADIAN RHYTHM; CONTROLLED STUDY; FLOW CYTOMETRY; HOURS AFTER LIGHT ONSET; HUMAN; HUMAN CELL; IN VIVO STUDY; LIGHT DARK CYCLE; MALE; MOUSE; MOUTH SQUAMOUS CELL CARCINOMA; NONHUMAN; PROLIFERATIVE INDEX; RATING SCALE; TUMOR CELL; TUMOR GROWTH; TUMOR VOLUME;

EID: 84873876909     PISSN: 11786930     EISSN: None     Source Type: Journal    
DOI: 10.2147/OTT.S39955     Document Type: Article

References (25)

1. Eismann EA, Lush E, Sephton SE. Circadian effects in cancer-relevant psychoneuroendocrine and immune pathways. Psychoneuroendocrinology. 2010;35(7):963-976.
2. Smolensky MH, Peppas NA. Chronobiology, drug delivery, and chronotherapeutics. Adv Drug Deliv Rev. 2007;59(9-10):828-851.
3. Murphy PJ, Campbell SS. Physiology of the circadian system in animals and humans. J Clin Neurophysiol. 1996;13(1):2-16.
4. Huang XL, Fu CJ, Bu RF. Role of circadian clocks in the development and therapeutics of cancer. J Int Med Res. 2011;39(6):2061-2066.
5. Lemmer B. Chronobiology, drug-delivery, and chronotherapeutics. Adv Drug Deliv Rev. 2007;59(9-10):825-827.
6. Lévi F. Circadian chronotherapy for human cancers. Lancet Oncol. 2001;2(5):307-315.
7. Jasser SA, Blask DE, Brainard GC. Light during darkness and cancer: relationships in circadian photoreception and tumor biology. Cancer Causes Control. 2006;17(4):515-523.
8. Fu L, Lee CC. The circadian clock: pacemaker and tumour suppressor. Nat Rev Cancer. 2003;3(5):350-361.
9. Klevecz RR, Braly PS. Circadian and ultradian cytokinetic rhythms of spontaneous human cancer. Ann N Y Acad Sci. 1991;618:257-276.
10. Sephton S, Spiegel D. Circadian disruption in cancer: a neuroendocrineimmune pathway from stress to disease? Brain Behav Immun. 2003;17(5):321-328.
11. Filipski E, Lévi F. Circadian disruption in experimental cancer processes. Integr Cancer Ther. 2009;8(4):298-302.
12. Manoharan S, Baskar AA, Manivasagam T, Subramanian P. Circadian rhythmicity of plasma lipid peroxidation and antioxidants in oral squamous cell carcinoma. Singapore Med J. 2005;46(4):184-188.
13. Manivasagam T, Subramanian P. Monosodium glutamate affects the temporal characteristics of biochemical variables in Wistar rats. Pol J Pharmacol. 2004;56(1):79-84.
14. Lévi F, Okyar A, Dulong S, Innominato PF, Clairambault J. Circadian timing in cancer treatments. Annu Rev Pharmacol Toxicol. 2010;50: 377-421.
15. Innominato PF, Lévi F., Bjarnason GA. Chronotherapy and the molecular clock: Clinical implications in oncology. Adv Drug Deliv Rev. 2010;62(9-10):979-1001.
16. Lévi F. Chronotherapeutics: the relevance of timing in cancer therapy. Cancer Causes Control. 2006;17(4):611-621.
17. Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin. 2005;55(2):74-108.
18. Kademani D, Bell RB, Schmidt BL, et al; the American Association of Oral and Maxillofacial Surgeons Task Force on Oral Cancer. Oral and maxillofacial surgeons treating oral cancer: a preliminary report from the American Association of Oral and Maxillofacial Surgeons Task Force on Oral Cancer. J Oral Maxillofac Surg. 2008;66(10):2151-2157.
19. Kademani D, Bell RB, Bagheri S, et al. Prognostic factors in intraoral squamous cell carcinoma: the influence of histologic grade. J Oral Maxillofac Surg. 2005;63(11):1599-1605.
20. Yang K, Cao YA, Shi C, et al. Quantum dot-based visual in vivo imaging for oral squamous cell carcinoma in mice. Oral Oncol. 2010;46(12): 864-868.
21. Yang K, Zhang FJ, Tang H, et al. In-vivo imaging of oral squamous cell carcinoma by EGFR monoclonal antibody conjugated near-infrared quantum dots in mice. Int J Nanomedicine. 2011;6:1739-1745.
22. Sato F, Wu Y, Bhawal UK, et al. PERIOD1 (PER1) has anti-apoptotic effects, and PER3 has pro-apoptotic effects during cisplatin (CDDP) treatment in human gingival cancer CA9-22 cells. Eur J Cancer. 2011;47(11):1747-1758.
23. Bjarnason GA, Jordan RC, Wood PA, et al. Circadian expression of clock genes in human oral mucosa and skin: association with specific cell-cycle phases. Am J Pathol. 2001;158(5):1793-1801.
24. Zieker D, Jenne I, Koenigsrainer I, et al. Circadian expression of clock- and tumor suppressor genes in human oral mucosa. Cell PhysiolBiochem. 2010;26(2):155-166.
25. Gery S, Komatsu N, Baldjyan L, Yu A, Koo D, Koeffler HP. The circadian gene per1 plays an important role in cell growth and DNA damage control in human cancer cells. Mol Cell. 2006;22(3):375-382.